ATL-193

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameATL-193
Drug Alias NameJMR-193eadenosine A2a receptor agonists (BMS/Adenosine Therapeutics)JMR 2037JMR-193ATL-193 +[6] 
ClassificationSmall molecules
Mechanisms of ActionAdenosine A2a receptor agonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsIschemiaInflammationMyocardial Infarction +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma CompanyAdenosine Therapeutics LLCBristol-Myers Squibb Company +[4] 
Active IndicationsN/A
Inactive IndicationsIschemiaInflammationMyocardial Infarction +[6] 

Other Information

ATC CodeN/A
Related LinksN/A